Home 2023

GlaxoSmithKline

Biomanufacturers Take a Two-Pronged Approach to Digitalization
Bioprocessing

Biomanufacturers Take a Two-Pronged Approach to Digitalization

Kathy Vuksanaj -
0
Digital Twins in Adjuvant Production
Bioprocessing

Digital Twins in Adjuvant Production

Christina Jackson -
0
Multiple Vaccine Technologies Converge on Respiratory Syncytial Virus
Insights

Multiple Vaccine Technologies Converge on Respiratory Syncytial Virus

Kathy Vuksanaj -
0
StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt
Cancer

StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt

Alex Philippidis -
0
Revolutionizing Monoclonal Antibody Production Monitoring
Bioprocessing

Revolutionizing Monoclonal Antibody Production Monitoring

John Sterling -
0
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Resources

Emerging Markets Collaborate to Succeed in Post-Pandemic World

GEN Staff Writer -
0
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Drug Discovery

Emerging Markets Collaborate to Succeed in Post-Pandemic World

GEN Staff Writer -
0
Protein Knockdowns May Obviate Genetic Knockouts
Drug Discovery

Protein Knockdowns May Obviate Genetic Knockouts

Jonathan D Grinstein, PhD -
0
StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts
Drug Discovery

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts

Alex Philippidis -
0
StockWatch: After Bluebird’s Second Approval, Investors Are Looking for More
GEN Edge

StockWatch: After Bluebird’s Second Approval, Investors Are Looking for More

Alex Philippidis -
0
123...64Page 1 of 64
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.